Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03335033 · ClinicalTrials.gov registry record · Phase 2
New Technologies to Determine Carotid Plaque Vulnerability in Patients With Significant Carotid Plaques
A Phase 2 study, sponsored by Mayo Clinic.
- Completed
- Registry status
- Phase 2
- Development phase
- 54
- Enrollment target
NCT03335033: Completed Phase 2 study, sponsored by Mayo Clinic.
NCT03335033 is a Phase 2 study that has completed, run by Mayo Clinic. The registered enrollment target is 54 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03335033, a Phase 2 study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 54 participants
- Enrollment target
Study Summary
The researchers are trying to determine if the characterization of "vulnerable" carotid artery plaques can be accomplished with ultrasound-based methods that look for vessels in the plaque and measure the plaque stiffness.
Interventions
- DEVICE Shear Wave Elastography
- COMBINATION_PRODUCT Contrast-enhanced ultrasound
- DEVICE Ultrasound Examination
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 54 participants |
| Start Date | 2017-11-15 |
| Est. Completion | 2022-01-30 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03335033
The ClinicalTrials.gov registry entry for NCT03335033 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 54 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Shear Wave Elastography is the first listed.
NCT03335033 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03335033 about?
NCT03335033 is a clinical study titled "New Technologies to Determine Carotid Plaque Vulnerability in Patients With Significant Carotid Plaques". The researchers are trying to determine if the characterization of "vulnerable" carotid artery plaques can be accomplished with ultrasound-based methods that look for vessels in the plaque and measure the plaque stiffness.
What is the current status of trial NCT03335033?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 54 participants. The study started on 2017-11-15. Estimated completion is 2022-01-30.
What interventions are being tested in trial NCT03335033?
The interventions under investigation include: Shear Wave Elastography (DEVICE), Contrast-enhanced ultrasound (COMBINATION_PRODUCT), Ultrasound Examination (DEVICE).
Who is sponsoring clinical trial NCT03335033?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.